Enzyme Linked Immunosorbent Assay (ELISA) is one of the promising techniques used for the detection and quantification of biological analytes such as peptides, proteins, antibodies, and hormones. This technique can be useful to provide a quick and cost-effective assay to measure the concentration of unknown antigen or antibody in a specific analyte. ELISA finds its extensive application as a diagnostic tool in medicines as well as to monitor and quality check-up procedures in drug development processes at various industries. ELISA can be performed by different type of methods that include direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA. The high sensitivity, flexibility and cost effectiveness of indirect ELISA makes it an ideal choice of most of the test kit manufacturers and thus possess the highest market share.

Request for Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1505

Market Dynamics

The Enzyme Linked Immunosorbent Assay (ELISA) Market is expanding owing to the increasing incidence of chronic diseases mainly in case of infectious diseases, vector borne diseases and cancer. According to the National Cancer Institute, cancer has a major impact on the population of U.S. and across the world. The NCI reports approximately 1,685,210 new cases of cancer were diagnosed in 2016. Also, reports demand for efficient detection tests that can be sufficed with the help of ELISA test kits. Moreover, increasing demand for cost-effective diagnostic tool is one of the factor aiding the growth of ELISA market, especially in the low and middle income economies. For instance, in October 2017, the Nigerian government and World Health Organization (WHO) launched a campaign to vaccinate around 874,000 people against yellow fever in two states of the country Kwara and Kogi in alliance with the International Coordination Group. The samples of the patients suspected with yellow fever were further tested with the help of ELISA test at the Pasteur Institute in Dakar. However, availability of alternate immunoassays and cross reactivity projected by these tests can hinder the market growth. Development of cost-effective ELISA tests with improved reliability and accuracy can provide potential opportunity for market players to strategize their growth in the global ELISA market.

Request for Customisation : https://www.coherentmarketinsights.com/insight/request-customization/1505

Key features of the study:

This report provides in-depth analysis of Enzyme Linked Immunosorbent Assay (ELISA) Market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2017 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global Enzyme Linked Immunosorbent Assay (ELISA) Market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans

Key companies covered as a part of this study includes Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global Enzyme Linked Immunosorbent Assay (ELISA) Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the Enzyme Linked Immunosorbent Assay (ELISA) Market

Detailed Segmentation:

Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Method:

Direct ELISA

Indirect ELISA

Sandwich ELISA

Competitive ELISA

Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Application:

Vaccine Development

Immunology

Diagnostics

Toxicology

Drug Monitoring & Pharmaceutical Industry

Transplantation

Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Technology:

Chemiluminescent

Colorimetric

Fluorescent

Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Geography:

By Method:

Direct ELISA

Indirect ELISA

Sandwich ELISA

Competitive ELISA

By Application:

Vaccine Development

Immunology

Diagnostics

Toxicology

Drug Monitoring & Pharmaceutical Industry

Transplantation

By Technology:

Chemiluminescent

Colorimetric

Fluorescent

By Country:

U.S.

Canada

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]